220 related articles for article (PubMed ID: 22461904)
21. Synergistic interaction between the non-phorbol ester-type promoter mirex and 12-O-tetradecanoylphorbol-13-acetate in mouse skin tumor promotion.
Meyer SA; Kim TW; Moser GJ; Monteiro-Riviere NA; Smart RC
Carcinogenesis; 1994 Jan; 15(1):47-52. PubMed ID: 8293547
[TBL] [Abstract][Full Text] [Related]
22. v-Ha-ras-induced mouse skin papillomas exhibit aberrant expression of keratin K13 as do their 7,12-dimethylbenz[a]anthracene/12-O-tetradecanoylphorbol-13-acetate -induced analogues.
Sutter C; Strickland JE; Welty DJ; Yuspa SH; Winter H; Schweizer J
Mol Carcinog; 1991; 4(6):467-76. PubMed ID: 1724371
[TBL] [Abstract][Full Text] [Related]
23. Enhanced sensitivity to tumor growth and development in multistage skin carcinogenesis by transforming growth factor-alpha-induced epidermal growth factor receptor activation but not p53 inactivation.
Shibata MA; Ward JM; Green JE; Merlino G
Mol Carcinog; 1997 Mar; 18(3):160-70. PubMed ID: 9115586
[TBL] [Abstract][Full Text] [Related]
24. Effects of dose and duration of treatment with the tumor-promoting agent, 12-O-tetradecanoylphorbol-13-acetate on mouse skin carcinogenesis.
Verma AK; Boutwell RK
Carcinogenesis; 1980 Mar; 1(3):271-6. PubMed ID: 22283009
[TBL] [Abstract][Full Text] [Related]
25. Characterization of benzo[a]pyrene-initiated mouse skin papillomas for Ha-ras mutations and protein kinase C levels.
Colapietro AM; Goodell AL; Smart RC
Carcinogenesis; 1993 Nov; 14(11):2289-95. PubMed ID: 8242857
[TBL] [Abstract][Full Text] [Related]
26. Methylation of the O6-methylguanine-DNA methyltransferase promoter suppresses expression in mouse skin tumors and varies with the tumor induction protocol.
Abdel-Fattah R; Glick A; Rehman I; Maiberger P; Hennings H
Int J Cancer; 2006 Feb; 118(3):527-31. PubMed ID: 16094607
[TBL] [Abstract][Full Text] [Related]
27. Papilloma development is delayed in osteopontin-null mice: implicating an antiapoptosis role for osteopontin.
Hsieh YH; Juliana MM; Hicks PH; Feng G; Elmets C; Liaw L; Chang PL
Cancer Res; 2006 Jul; 66(14):7119-27. PubMed ID: 16849558
[TBL] [Abstract][Full Text] [Related]
28. Genetic alterations cooperate with v-Ha-ras to accelerate multistage carcinogenesis in TG.AC transgenic mouse skin.
Owens DM; Spalding JW; Tennant RW; Smart RC
Cancer Res; 1995 Jul; 55(14):3171-8. PubMed ID: 7606738
[TBL] [Abstract][Full Text] [Related]
29. Enhanced skin carcinogenesis in transgenic mice with high expression of glutathione peroxidase or both glutathione peroxidase and superoxide dismutase.
Lu YP; Lou YR; Yen P; Newmark HL; Mirochnitchenko OI; Inouye M; Huang MT
Cancer Res; 1997 Apr; 57(8):1468-74. PubMed ID: 9108447
[TBL] [Abstract][Full Text] [Related]
30. Haploinsufficiency of the cdc2l gene contributes to skin cancer development in mice.
Chandramouli A; Shi J; Feng Y; Holubec H; Shanas RM; Bhattacharyya AK; Zheng W; Nelson MA
Carcinogenesis; 2007 Sep; 28(9):2028-35. PubMed ID: 17389615
[TBL] [Abstract][Full Text] [Related]
31. IL-13 but not IL-4 signaling via IL-4Rα protects mice from papilloma formation during DMBA/TPA two-step skin carcinogenesis.
Rothe M; Quarcoo D; Chashchina AA; Bozrova SV; Qin Z; Nedospasov SA; Blankenstein T; Kammertoens T; Drutskaya MS
Cancer Med; 2013 Dec; 2(6):815-25. PubMed ID: 24403255
[TBL] [Abstract][Full Text] [Related]
32. Susceptibility of 129/SvEv mice in two-stage carcinogenesis protocols to 12-O-tetradecanoylphorbol-13-acetate promotion.
Reiners JJ; Singh KP
Carcinogenesis; 1997 Mar; 18(3):593-7. PubMed ID: 9067561
[TBL] [Abstract][Full Text] [Related]
33. IL-1 alpha, innate immunity, and skin carcinogenesis: the effect of constitutive expression of IL-1 alpha in epidermis on chemical carcinogenesis.
Murphy JE; Morales RE; Scott J; Kupper TS
J Immunol; 2003 Jun; 170(11):5697-703. PubMed ID: 12759452
[TBL] [Abstract][Full Text] [Related]
34. Suppressor role of activating transcription factor 2 (ATF2) in skin cancer.
Bhoumik A; Fichtman B; Derossi C; Breitwieser W; Kluger HM; Davis S; Subtil A; Meltzer P; Krajewski S; Jones N; Ronai Z
Proc Natl Acad Sci U S A; 2008 Feb; 105(5):1674-9. PubMed ID: 18227516
[TBL] [Abstract][Full Text] [Related]
35. Low iron diet retards 12-O-tetradecanoyl phorbol-13-acetate-mediated tumor promotion in murine skin.
Bhasin G; Kauser H; Athar M
Arch Toxicol; 2004 May; 78(5):283-9. PubMed ID: 14997284
[TBL] [Abstract][Full Text] [Related]
36. Protection against 12-O-tetradecanoylphorbol-13-acetate induced skin-hyperplasia and tumor promotion, in a two-stage carcinogenesis mouse model, by the 2,3-dimethyl-6(2-dimethylaminoethyl)-6H-indolo-[2,3-b]quinoxaline analogue of ellipticine.
Skarin T; Rozell BL; Bergman J; Toftgård R; Möller L
Chem Biol Interact; 1999 Sep; 122(2):89-106. PubMed ID: 10528995
[TBL] [Abstract][Full Text] [Related]
37. A simple phenolic antioxidant protocatechuic acid enhances tumor promotion and oxidative stress in female ICR mouse skin: dose-and timing-dependent enhancement and involvement of bioactivation by tyrosinase.
Nakamura Y; Torikai K; Ohto Y; Murakami A; Tanaka T; Ohigashi H
Carcinogenesis; 2000 Oct; 21(10):1899-907. PubMed ID: 11023549
[TBL] [Abstract][Full Text] [Related]
38. Lack of effect of retinoic acid and fluocinolone acetonide on mirex tumor promotion indicates a novel mirex mechanism.
Kim TW; Smart RC
Carcinogenesis; 1995 Sep; 16(9):2199-204. PubMed ID: 7554075
[TBL] [Abstract][Full Text] [Related]
39. Alterations in protein kinase C isozymes alpha and beta 2 in activated Ha-ras containing papillomas in the absence of an increase in diacylglycerol.
Mills KJ; Bocckino SB; Burns DJ; Loomis CR; Smart RC
Carcinogenesis; 1992 Jul; 13(7):1113-20. PubMed ID: 1638676
[TBL] [Abstract][Full Text] [Related]
40. Independent genetic control of early and late stages of chemically induced skin tumors in a cross of a Japanese wild-derived inbred mouse strain, MSM/Ms.
Okumura K; Sato M; Saito M; Miura I; Wakana S; Mao JH; Miyasaka Y; Kominami R; Wakabayashi Y
Carcinogenesis; 2012 Nov; 33(11):2260-8. PubMed ID: 22843548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
